|

Infusion of alloreactive NK cells Clinical Trials

1 actively recruiting trial

Top Sponsors

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Indications

  • Natural Killer Cell1
  • Minimal Residual Disease1
  • Acute Myeloid Leukemia1
  • Cancer1

Other1 trial

Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.